Asterias Biotherapeutics (NYSE: AST) (a subsidiary of BioTime; NYSE: BTX)

Four cell lines from which multiple therapeutic product candidates may be selected for development indications in the fields of neurology (including s....

Get a Demo and See the Full Profile

Get a demo today to see profiles of Asterias Biotherapeutics (NYSE: AST) (a subsidiary of BioTime; NYSE: BTX) plus 6037 other startups.

Learn More About Asterias Biotherapeutics (NYSE: AST) (a subsidiary of BioTime; NYSE: BTX)

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

Competing Startups

More